1. Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy
   Ke Wu et al, 2018, Clinical Immunology CrossRef
2. Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases
   Elisabeth Grobet-Jeandin et al, 2024, Nature Reviews Urology CrossRef
3. Neoadjuvant intra-arterial chemotherapy using an original four-lumen double-balloon catheter for locally advanced uterine cervical cancer
   Tomohito Tanaka et al, 2018, Oncotarget CrossRef
4. Novel Software-Assisted Hemodynamic Evaluation of Pelvic Flow During Chemoperfusion of Pelvic Arteries for Bladder Cancer: Double- Versus Single-Balloon Technique
   Kiyohito Yamamoto et al, 2016, CardioVascular and Interventional Radiology CrossRef
5. The treatment of muscle-invasive bladder cancer in geriatric patients
   Bernhard Grubmueller et al, 2016, Current Opinion in Urology CrossRef
6. Management of Clinically Regional Node-Positive Urothelial Carcinoma of the Bladder
   Chanan Reitblat et al, 2021, Current Oncology Reports CrossRef
7. Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future
   Tomokazu Kimura et al, 2020, Japanese Journal of Clinical Oncology CrossRef
8. Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer
   Haruhito Azuma et al, 2018, International Journal of Oncology CrossRef